| Product NDC: | 60793-411 |
| Proprietary Name: | Flector |
| Non Proprietary Name: | Diclofenac Epolamine |
| Active Ingredient(s): | 180 mg/1 & nbsp; Diclofenac Epolamine |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | PATCH |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 60793-411 |
| Labeler Name: | King Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021234 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20080114 |
| Package NDC: | 60793-411-30 |
| Package Description: | 6 POUCH in 1 CARTON (60793-411-30) > 5 PATCH in 1 POUCH (60793-411-05) |
| NDC Code | 60793-411-30 |
| Proprietary Name | Flector |
| Package Description | 6 POUCH in 1 CARTON (60793-411-30) > 5 PATCH in 1 POUCH (60793-411-05) |
| Product NDC | 60793-411 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Diclofenac Epolamine |
| Dosage Form Name | PATCH |
| Route Name | TOPICAL |
| Start Marketing Date | 20080114 |
| Marketing Category Name | NDA |
| Labeler Name | King Pharmaceuticals, Inc. |
| Substance Name | DICLOFENAC EPOLAMINE |
| Strength Number | 180 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |